The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system.
about
Restriction enzymes in the analysis of genetic alterations responsible for cancer progression.Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotypingComparison of the novel quantitative ARMS assay and an enriched PCR-ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses.Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations.Validation of a Multiplex Allele-Specific Polymerase Chain Reaction Assay for Detection of KRAS Gene Mutations in Formalin-Fixed, Paraffin-Embedded Tissues from Colorectal Cancer Patients.Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.DEspR roles in tumor vasculo-angiogenesis, invasiveness, CSC-survival and anoikis resistance: a 'common receptor coordinator' paradigm.Oncomutations as biomarkers of cancer risk.Optimized allele-specific real-time PCR assays for the detection of common mutations in KRAS and BRAF.KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer.DNA enrichment by allele-specific hybridization (DEASH): a novel method for haplotyping and for detecting low-frequency base substitutional variants and recombinant DNA molecules.A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samplesExtendable blocking probe in reverse transcription for analysis of RNA variants with superior selectivity.Comment on 'KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer.High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis
P2860
Q34535999-62B6F9F3-8BC9-4A2A-84D1-86410354C743Q34760933-06109969-EBF1-4EA4-8E47-2E10E2B39644Q35588895-467A255E-C1DB-40DC-95BC-4A685A62820CQ35877954-212E0C2F-89D6-4D9A-ABD9-074D18FDC279Q35905048-423F6A0F-BDA5-49F0-85C0-9919F636D944Q36277022-D753BB73-2942-4266-B057-92076579C1C6Q37273361-DC37851D-A108-48AF-9692-606EA0AE9BBFQ37499770-E91AC222-649F-4E0F-A98D-7A4B2FD6BD88Q37782592-7456FE08-5EB0-4ACC-AC42-07B0B07A614DQ38412630-67D44065-DF8E-4DA4-9CBA-5D91762066B7Q39763671-6A1F1298-41D4-4BC3-9057-3ED65B284F0CQ40830086-97FB1FE3-7CA5-4E80-ADC5-7C2D08BD4DD3Q41703846-A1AED1AB-109B-4D5F-ADE7-88D3F29AFD71Q42154106-879180BF-0BB4-4494-9A08-4B1786EFC272Q42585933-8666EF1B-CE6D-4B94-99D8-D99EF59F4911Q55032174-A6FDEC46-9546-4CC4-980B-64839F692404Q57785902-A2034085-B826-4039-BA74-B4547888C380
P2860
The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
The detection of K-ras mutatio ...... on-refractory mutation system.
@ast
The detection of K-ras mutatio ...... on-refractory mutation system.
@en
type
label
The detection of K-ras mutatio ...... on-refractory mutation system.
@ast
The detection of K-ras mutatio ...... on-refractory mutation system.
@en
prefLabel
The detection of K-ras mutatio ...... on-refractory mutation system.
@ast
The detection of K-ras mutatio ...... on-refractory mutation system.
@en
P2093
P2860
P356
P1476
The detection of K-ras mutatio ...... on-refractory mutation system.
@en
P2093
Callaghan K
Charlesworth NR
McCarthy TL
Northover JM
P2860
P2888
P304
P356
10.1038/BJC.1998.212
P407
P577
1998-04-01T00:00:00Z